Dry Eye Syndrome Prevalence to Grow in 14 Top Markets, States Black Swan Analysis in Comprehensive Report Published at MarketPublishers.com
23 Sep 2016 • by Natalie Aster
LONDON – Dry eye syndrome (DES), also termed as keratoconjunctivitis sicca (KCS), is a multifactorial disorder of the eye, which is caused by dryness, deficiency of tear secretion (hyposecretive), or an increase in tear film evaporation. It leads to symptoms of discomfort like disturbance of vision and an unstable tear film. Middle-aged adults and older people are affected to the fullest extent owing to the high prevalence rates of contact lens use, autoimmune abnormalities, systemic effects of drugs, and refractive surgeries in this age group.
Worldwide, the prevalence rate of DES reaches up to 33%, and it is projected to range from <0.1% to 33% across various countries and differs between 5% to >30% in different age groups from pole to pole. Additionally, DES is more common in women than in men.
Comprehensive market research report “Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026” developed by Black Swan Analysis covers the present-day prevalent population for DES across top 14 markets including France, Italy, Germany, the UK, Japan, the USA, Spain, China, India, Mexico, Australia, Brazil, Canada and South Korea; split by five-year age cohort and gender. Alongside the actual prevalence rates, the study also includes a review of the risk factors, diagnosis and prognosis of DES in tandem with specific variations on the basis of geographic region and ethnicity. The report offers shrewd insights into the prevalence of the subdivided DES types and pinpoints patient segments that have high potential. The study also quantifies the various main symptoms and co-morbidities of DES. The research report offers accurate information pertaining to clinical research in study sizing and realistic patient recruitment for different nations. The report examines the influence from specific co-morbid conditions on the prevalent population with DES; it identifies sub-populations within DES which need treatment; and gives a keen understanding of the particular markets that have the biggest number of DES patients.
More comprehensive publications by the publisher can be found at Black Swan Analysis page.